Endometrial hyperplasia screening

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]Associate Editor(s)-in-Chief: Swathi Venkatesan, M.B.B.S.[2]

Routine screening for endometrial hyperplasia or endometrial carcinoma is not recommended.

• Women receiving unopposed estrogens should undergo endometrial sampling once every 2 years. ^[1]
• Particularly if endometrial hyperstimulation was documented previously and is not been treated by short-term progestins.
• If high-risk individual requests an endometrial evaluation before or during HRT.
• Women at high risk for endometrial carcinoma, such as history of Lynch II syndrome.

Template:WikiDoc Sources